First Covid-19 vaccine to reach phase-1 trial is safe, say researchers

Several teams across the world are in a race to develop a vaccine for coronavirus infection

Days after US drugmaker Moderna claimed that the phase-1 trial of its Covid-19 vaccine has shown positive results, a new research published in The Lancet journal on Friday reported that vaccine, the first to reach phase-I clinical trial, is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans.

The trial was conducted by researchers at several laboratories and included 108 participants aged 18-60. The vaccine produced neutralising antibodies and a response mediated by the immune system's T-cells against the novel coronavirus, SARS-CoV-2.

Several teams across the world are in a race to develop a